SCANA ASA (SCANA.OL) Fundamental Analysis & Valuation

OSL:SCANA • NO0003053308

1.518 NOK
0 (0%)
Last: Mar 6, 2026, 07:00 PM

This SCANA.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall SCANA gets a fundamental rating of 3 out of 10. We evaluated SCANA against 109 industry peers in the Machinery industry. SCANA may be in some trouble as it scores bad on both profitability and health. SCANA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. SCANA.OL Profitability Analysis

1.1 Basic Checks

  • In the past year SCANA has reported negative net income.
  • SCANA had a positive operating cash flow in the past year.
  • In multiple years SCANA reported negative net income over the last 5 years.
  • Each year in the past 5 years SCANA had a positive operating cash flow.
SCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFSCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

1.2 Ratios

  • The Return On Assets of SCANA (-2.42%) is worse than 78.90% of its industry peers.
  • SCANA's Return On Equity of -5.78% is on the low side compared to the rest of the industry. SCANA is outperformed by 77.06% of its industry peers.
Industry RankSector Rank
ROA -2.42%
ROE -5.78%
ROIC N/A
ROA(3y)2.56%
ROA(5y)3.28%
ROE(3y)6.37%
ROE(5y)7.25%
ROIC(3y)N/A
ROIC(5y)N/A
SCANA.OL Yearly ROA, ROE, ROICSCANA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

1.3 Margins

  • Looking at the Gross Margin, with a value of 57.49%, SCANA is in the better half of the industry, outperforming 77.06% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SCANA has grown nicely.
  • The Profit Margin and Operating Margin are not available for SCANA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.36%
GM growth 5Y5.31%
SCANA.OL Yearly Profit, Operating, Gross MarginsSCANA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 -60

3

2. SCANA.OL Health Analysis

2.1 Basic Checks

  • SCANA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SCANA has about the same amout of shares outstanding than it did 1 year ago.
  • SCANA has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SCANA has a worse debt to assets ratio.
SCANA.OL Yearly Shares OutstandingSCANA.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
SCANA.OL Yearly Total Debt VS Total AssetsSCANA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • The Debt to FCF ratio of SCANA is 3.56, which is a good value as it means it would take SCANA, 3.56 years of fcf income to pay off all of its debts.
  • SCANA has a better Debt to FCF ratio (3.56) than 66.06% of its industry peers.
  • SCANA has a Debt/Equity ratio of 0.53. This is a neutral value indicating SCANA is somewhat dependend on debt financing.
  • SCANA has a Debt to Equity ratio (0.53) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 3.56
Altman-Z N/A
ROIC/WACCN/A
WACC8.36%
SCANA.OL Yearly LT Debt VS Equity VS FCFSCANA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • SCANA has a Current Ratio of 1.03. This is a normal value and indicates that SCANA is financially healthy and should not expect problems in meeting its short term obligations.
  • SCANA's Current ratio of 1.03 is on the low side compared to the rest of the industry. SCANA is outperformed by 79.82% of its industry peers.
  • SCANA has a Quick Ratio of 1.03. This is a bad value and indicates that SCANA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.83, SCANA is not doing good in the industry: 63.30% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.83
SCANA.OL Yearly Current Assets VS Current LiabilitesSCANA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

4

3. SCANA.OL Growth Analysis

3.1 Past

  • SCANA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -144.13%.
  • Looking at the last year, SCANA shows a very negative growth in Revenue. The Revenue has decreased by -18.95% in the last year.
  • Measured over the past years, SCANA shows a very strong growth in Revenue. The Revenue has been growing by 39.30% on average per year.
EPS 1Y (TTM)-144.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%246.67%
Revenue 1Y (TTM)-18.95%
Revenue growth 3Y21.66%
Revenue growth 5Y39.3%
Sales Q2Q%0.42%

3.2 Future

  • SCANA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 159.31% yearly.
  • SCANA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.97% yearly.
EPS Next Y444.83%
EPS Next 2Y159.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.6%
Revenue Next 2Y7.97%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SCANA.OL Yearly Revenue VS EstimatesSCANA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
SCANA.OL Yearly EPS VS EstimatesSCANA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0 0.05 0.1 0.15

5

4. SCANA.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • SCANA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 14.74 indicates a correct valuation of SCANA.
  • Based on the Price/Forward Earnings ratio, SCANA is valued a bit cheaper than the industry average as 62.39% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of SCANA to the average of the S&P500 Index (24.60), we can say SCANA is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 14.74
SCANA.OL Price Earnings VS Forward Price EarningsSCANA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as SCANA.
  • 89.91% of the companies in the same industry are more expensive than SCANA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.29
EV/EBITDA 10.19
SCANA.OL Per share dataSCANA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • SCANA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SCANA's earnings are expected to grow with 159.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y159.31%
EPS Next 3YN/A

0

5. SCANA.OL Dividend Analysis

5.1 Amount

  • SCANA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SCANA.OL Fundamentals: All Metrics, Ratios and Statistics

SCANA ASA

OSL:SCANA (3/6/2026, 7:00:00 PM)

1.518

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-06
Earnings (Next)N/A
Inst Owners2.94%
Inst Owner ChangeN/A
Ins Owners2.62%
Ins Owner ChangeN/A
Market Cap701.15M
Revenue(TTM)1.60B
Net Income(TTM)-36.30M
Analysts86.67
Price Target1.94 (27.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.84%
Min Revenue beat(2)-10.47%
Max Revenue beat(2)8.79%
Revenue beat(4)2
Avg Revenue beat(4)-4.62%
Min Revenue beat(4)-19.55%
Max Revenue beat(4)8.79%
Revenue beat(8)5
Avg Revenue beat(8)0.5%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.74
P/S 0.44
P/FCF 5.29
P/OCF 3.9
P/B 1.12
P/tB 2.84
EV/EBITDA 10.19
EPS(TTM)-0.08
EYN/A
EPS(NY)0.1
Fwd EY6.79%
FCF(TTM)0.29
FCFY18.9%
OCF(TTM)0.39
OCFY25.62%
SpS3.46
BVpS1.36
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.42%
ROE -5.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.49%
FCFM 8.3%
ROA(3y)2.56%
ROA(5y)3.28%
ROE(3y)6.37%
ROE(5y)7.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.36%
GM growth 5Y5.31%
F-Score4
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 3.56
Debt/EBITDA 3.04
Cap/Depr 38.39%
Cap/Sales 2.95%
Interest Coverage N/A
Cash Conversion 163.57%
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 0.83
Altman-Z N/A
F-Score4
WACC8.36%
ROIC/WACCN/A
Cap/Depr(3y)47.82%
Cap/Depr(5y)37.5%
Cap/Sales(3y)3.07%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-144.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%246.67%
EPS Next Y444.83%
EPS Next 2Y159.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.95%
Revenue growth 3Y21.66%
Revenue growth 5Y39.3%
Sales Q2Q%0.42%
Revenue Next Year9.6%
Revenue Next 2Y7.97%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-108.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2728.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y102.29%
FCF growth 3Y37.83%
FCF growth 5Y28.39%
OCF growth 1Y22.59%
OCF growth 3Y36.91%
OCF growth 5Y35.69%

SCANA ASA / SCANA.OL FAQ

What is the fundamental rating for SCANA stock?

ChartMill assigns a fundamental rating of 3 / 10 to SCANA.OL.


Can you provide the valuation status for SCANA ASA?

ChartMill assigns a valuation rating of 5 / 10 to SCANA ASA (SCANA.OL). This can be considered as Fairly Valued.


Can you provide the profitability details for SCANA ASA?

SCANA ASA (SCANA.OL) has a profitability rating of 2 / 10.


What is the expected EPS growth for SCANA ASA (SCANA.OL) stock?

The Earnings per Share (EPS) of SCANA ASA (SCANA.OL) is expected to grow by 444.83% in the next year.